cell and gene therapy world


Phacilitate Leaders Forum 2018 - Recap videos

Phacilitate Leaders World 2018 saw over 1500 attendees from the advanced therapies industry and beyond come together to discuss the latest innovations, achievements and challenges face by the industry.

This year, the World Stem Cell Summit also joined the proverbial party adding a new dimension to this 15-year-old meeting. The WCSC community bridge a crucial gap between the science and the clinic.

Subscribe to Phacilitate:Exchange, a brand new digital portal, to keep up with the industry 365 days a year. www.phacilitate.co.uk


Phacilitate’s recent event brought together over 1500 senior executives from across the cell, gene, immunotherapy, stem cell and cord blood sectors for 5 days of networking and strategic discussions in the January sunshine.

  • "The event reflected the fantastic growing enthusiasm around cell and gene therapy, including small and large companies, investors and regulators. It was great to see everyone so engaged and so positive. The event really gives you the “pulse” of what is happening right now in cell and gene therapy."
    Anne-Virginie Eggimann,
  • “Great program, great people, great venue.”
    Klaus Kühlcke
    Managing Director, EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.”
    Nathalie Clement
    Associate Director, Powell Gene Therapy Center, University of Florida
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • "It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives."
    Kurt Gielen
    Acquisition & Business Development Manager, BioMedical Materials, Chemelot Campus B.V.
  • “Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.”
    Steven Goodman
    Director, Strategy and Engagement, GSK